Diagnostic Approach for Hallucinations in Seniors

Initial Evaluation and Differential Diagnoses

A comprehensive medical workup is essential for seniors experiencing hallucinations, and the American Geriatrics Society recommends a thorough neurological and psychiatric evaluation to rule out secondary causes, with appropriate neuroimaging (preferably MRI) to exclude intracranial processes requiring intervention 1
The assessment should include evaluating for preserved insight, as this can help narrow the differential diagnosis, and the American Academy of Neurology suggests that preserved insight suggests conditions like Charles Bonnet Syndrome 1
Accompanying symptoms such as altered mental status, delirium, or other psychotic symptoms should be evaluated, and the American Psychiatric Association recommends a thorough assessment of these symptoms 1
Medication use, especially anticholinergics, steroids, dopaminergic agents, should be screened as potential contributors to hallucinations, and the American Medical Association suggests that medication side effects should be considered in the differential diagnosis 1

Charles Bonnet Syndrome is characterized by recurrent, vivid visual hallucinations, insight that what is seen is not real, no other neurological or medical diagnosis to explain the hallucinations, and some degree of vision loss, with a prevalence ranging from 15% to 60% among patients with ophthalmologic disorders, according to the American Academy of Ophthalmology 2
Neurological disorders such as Parkinson's disease, dementia with Lewy bodies, epilepsy, can present with hallucinations, and the American Academy of Neurology recommends evaluating for these conditions 1
Psychiatric disorders such as schizophrenia, bipolar disorder, depression with psychotic features should be assessed, and the American Psychiatric Association suggests that a thorough psychiatric evaluation is essential 1

Laboratory tests such as complete blood count (CBC), comprehensive metabolic panel, toxicology screen, and urinalysis should be performed to assess for underlying causes, and the American Medical Association recommends these tests as part of the diagnostic workup 1
Neuroimaging, preferably brain MRI, is recommended to better visualize structural abnormalities, and the American College of Radiology suggests that MRI is the preferred imaging modality 1
Additional testing such as electroencephalogram (EEG), lumbar puncture, formal ophthalmological examination may be necessary based on clinical suspicion, and the American Academy of Neurology recommends these tests in specific situations 1
Management considerations include educating patients and caregivers about Charles Bonnet Syndrome, recommending self-management techniques, and considering referral for vision rehabilitation, according to the American Academy of Ophthalmology 2
Treatment should target the underlying cause of hallucinations, and the American Psychiatric Association recommends a tailored approach to treatment 1

The American Geriatrics Society recommends using a systematic DICE approach (Describe, Investigate, Create, Evaluate) prioritizing non-pharmacologic interventions first, with pharmacologic treatment reserved for hallucinations causing significant distress or functional impairment 3
Ask caregivers to describe the hallucinations to understand the specific context, frequency, and severity, including timing and triggers, content specificity, patient insight, distress level, and modality 3
The modality of hallucinations should be assessed, including whether they are purely visual or also include auditory hallucinations 4

A comprehensive evaluation should be performed to identify treatable causes before considering psychotropics, including medication review, laboratory tests, vision assessment, pain evaluation, and environmental factors 3
Pain evaluation is a critical component, as undiagnosed pain is a common contributor in dementia patients 3

Visual hallucinations occur in up to 80% of patients with dementia with Lewy bodies (DLB) and are a core diagnostic criterion 5, 4
In DLB, hallucinations are typically well-formed, recurrent, and may occur early in disease course, and are associated with cognitive fluctuations, parkinsonism, and REM sleep behavior disorder 5

Non-pharmacologic interventions, such as education and reassurance, self-management techniques, environmental modifications, and treating underlying causes, should be implemented before medications 3
Cholinesterase inhibitors, such as rivastigmine and donepezil, are preferred for treating hallucinations in DLB, as they may reduce hallucinations while improving cognition 5

Assessment tools, such as the Neuropsychiatric Inventory (NPI) and the North-East Visual Hallucination Interview (NEVHI), should be used to track treatment response and adjust interventions based on changing symptoms and disease progression 5, 4
The American Geriatrics Society recommends regular reassessment for treatment response and adverse effects, and adjusting interventions based on changing symptoms and disease progression 3